top of page

Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trial

James S. H. Wong, Mohammadali Nikoo, Jean N. Westenberg, et al.

February 12, 2021

This method may eliminate withdrawal during transitions to buprenorphine. Safe in inpatient settings with appropriate monitoring.

bottom of page